Lpl Financial LLC Krystal Biotech, Inc. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 1,147 shares of KRYS stock, worth $223,160. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,147

Holding current value

$223,160

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 08, 2024	BUY	$174.7 - $213.66 $200,380 - $245,068	1,147 New	1,147 $208,000
Q4 2023 Feb 14, 2024	BUY	$96.0 - $128.29 $158,880 - $212,319	1,655 New	1,655 $205,000

Others Institutions Holding KRYS

# of Institutions

311

Shares Held

24.4M

Call Options Held

483K

Put Options Held

364K

Black Rock Inc. New York, NY

3.95M
Shares

$768 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

2.85M
Shares

$554 Million
0.01% of portfolio
Avoro Capital Advisors LLC New York, NY

2.62M
Shares

$510 Million
7.18% of portfolio
State Street Corp Boston, MA

1.45M
Shares

$283 Million
0.01% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

988K
Shares

$192 Million
9.67% of portfolio

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.99B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account